4//SEC Filing
Burns James William 4
Accession 0001439222-24-000140
CIK 0001439222other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:08 PM ET
Size
7.2 KB
Accession
0001439222-24-000140
Insider Transaction Report
Form 4
Burns James William
Chief Legal Officer
Transactions
- Sale
Common stock
2024-11-07$52.00/sh−13,411$697,372→ 24,041 total - Sale
Common stock
2024-11-07$52.56/sh−8,341$438,403→ 15,700 total
Footnotes (4)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $51.33 to $52.32. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]Includes 3,091 shares purchased through the Company's employee stock purchase plan.
- [F4]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $52.33 to $52.88. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001900772
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 4:08 PM ET
- Size
- 7.2 KB